Zach Hartman, PhD Positions For 2018: Oncology And Immunotherapy In Focus – Seeking Alpha
|
Zach Hartman, PhD Positions For 2018: Oncology And Immunotherapy In Focus
Seeking Alpha Cell therapy is going to be a big factor in 2018, with companies like Gilead and Juno Therapeutics leading the charge. Gene therapies have also been boiling in the kettle in 2017, and we're almost certain to see some of our first approvals for viral … |
